https://www.businesswire.com/news/home/20260107798042/en/4Moving-Biotech-Receives-FDA-IND-Clearance-for-4P004-Strengthening-Its-Position-as-a-Leading-Innovator-in-Disease-Modifying-Osteoarthritis-Therapeutics
4Moving Biotech Receives FDA IND Clearance for 4P004, Strengthening Its Position as a Leading...
4Moving Biotech Receives FDA IND Clearance for 4P004
https://www.businesswire.com/news/home/20250326675460/en/Health-Canada-Authorizes-4Moving-Biotech-to-Launch-Phase-2a-INFLAM-MOTION-Clinical-Trial-for-Knee-Osteoarthritis
Health Canada Authorizes 4Moving Biotech to Launch Phase 2a INFLAM MOTION Clinical Trial for Knee...
Health Canada Authorizes 4Moving Biotech to Launch Phase 2a INFLAM MOTION Clinical Trial for Knee Osteoarthritis